EU Industry Calls for More Dialogue on Proposed Pharmacovigilance Fees

While manufacturers support a strong pharmacovigilance system to ensure patient safety, the proposed costs are a source of concern, “especially in light of the annual saving for the pharmaceutical industry of 145 million euros (US $201 million) that was anticipated in the 2008 European Commission ‘impact assessment,’” a coalition of five trade groups says.
International Pharmaceutical Regulatory Monitor